These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9511045)

  • 81. Characterization of integron mediated antimicrobial resistance in Salmonella isolated from diseased swine.
    White DG; Zhao S; McDermott PF; Ayers S; Friedman S; Sherwood J; Breider-Foley M; Nolan LK
    Can J Vet Res; 2003 Jan; 67(1):39-47. PubMed ID: 12528827
    [TBL] [Abstract][Full Text] [Related]  

  • 82. AcrAB Efflux System: Expression and Contribution to Fluoroquinolone Resistance in Klebsiella spp.
    Mazzariol A; Zuliani J; Cornaglia G; Rossolini GM; Fontana R
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3984-6. PubMed ID: 12435706
    [TBL] [Abstract][Full Text] [Related]  

  • 83. High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA.
    Mazzariol A; Tokue Y; Kanegawa TM; Cornaglia G; Nikaido H
    Antimicrob Agents Chemother; 2000 Dec; 44(12):3441-3. PubMed ID: 11083655
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli.
    Kern WV; Oethinger M; Jellen-Ritter AS; Levy SB
    Antimicrob Agents Chemother; 2000 Apr; 44(4):814-20. PubMed ID: 10722475
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Role of the acrAB locus in organic solvent tolerance mediated by expression of marA, soxS, or robA in Escherichia coli.
    White DG; Goldman JD; Demple B; Levy SB
    J Bacteriol; 1997 Oct; 179(19):6122-6. PubMed ID: 9324261
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli.
    Oethinger M; Podglajen I; Kern WV; Levy SB
    Antimicrob Agents Chemother; 1998 Aug; 42(8):2089-94. PubMed ID: 9687412
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations.
    Wang H; Dzink-Fox JL; Chen M; Levy SB
    Antimicrob Agents Chemother; 2001 May; 45(5):1515-21. PubMed ID: 11302820
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Association of organic solvent tolerance and fluoroquinolone resistance in clinical isolates of Escherichia coli.
    Oethinger M; Kern WV; Goldman JD; Levy SB
    J Antimicrob Chemother; 1998 Jan; 41(1):111-4. PubMed ID: 9511045
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Improvement of organic solvent tolerance level of Escherichia coli by overexpression of stress-responsive genes.
    Aono R
    Extremophiles; 1998 Aug; 2(3):239-48. PubMed ID: 9783171
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Mechanisms of action and resistance of older and newer fluoroquinolones.
    Hooper DC
    Clin Infect Dis; 2000 Aug; 31 Suppl 2():S24-8. PubMed ID: 10984324
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Mechanisms of fluoroquinolone resistance: an update 1994-1998.
    Piddock LJ
    Drugs; 1999; 58 Suppl 2():11-8. PubMed ID: 10553699
    [TBL] [Abstract][Full Text] [Related]  

  • 92.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 93.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 94.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 5.